A human trial has begun or is set to begin on a therapy that aims to make cells young again, with some outlets reporting that it has already been administered to a person. The trial, which has been cleared by the FDA, is a first of its kind and involves cellular reprogramming. The research, which is being led by a figure associated with longevity science, including Dr. David Sinclair, has garnered significant attention for its potential to impact human aging.